PREVALENCE OF MUTATIONS IN EGFR, KRAS AND BRAF IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AS ASSESSED BY A PANEL OF PCR-BASED ASSAYS

被引：0
|
作者：
O'Donnell, Patrick
Current, Robert
Ferguson, Jane
Chien, Shih-Chang
Wen, Wei
Tsan, Alison
Newton, Nick
Jung, Laura
Bauer, Keith
Langland, Rachel
Brophy, Victoria
Schoenbrunner, Nancy
Myers, Thomas
Soviero, Stephen
Lawrence, Jeffrey
Wu, Lin
机构：
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
EGFR mutations; Kras mutations; BRAF mutations; molecular diagnostics;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1533 / S1534
页数：2
相关论文
共 50 条
  • [1] POPULATION BASED STUDY OF THE PREVALENCE OF EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Skov, Birgit G.
    Hogdall, Estrid
    Clementsen, Paul
    Krasnik, Mark
    Larsen, Klaus R.
    Sorensen, Jens B.
    Mellemgaard, Anders
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1082 - S1083
  • [2] Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
    Kim, Seung Tae
    Sung, Jae Sook
    Jo, Uk Hyun
    Park, Kyong Hwa
    Shin, Sang Won
    Kim, Yeul Hong
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [3] Uncommon EGFR mutations in advanced non-small cell lung cancer
    O'Kane, Grainne M.
    Bradbury, Penelope A.
    Feld, Ronald
    Leighl, Natasha B.
    Liu, Geoffrey
    Pisters, Katherine -M.
    Kamel-Reid, Suzanne
    Tsao, Ming S.
    Shepherd, Frances A.
    LUNG CANCER, 2017, 109 : 137 - 144
  • [4] Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
    Sun, Jong-Mu
    Hwang, Deok Won
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    PLOS ONE, 2013, 8 (05):
  • [5] The prevalence of EGFR mutations in non-small cell lung cancer in an unselected Caucasian population
    Skov, Birgit G.
    Hogdall, Estrid
    Clementsen, Paul
    Krasnik, Mark
    Larsen, Klaus Richter
    Sorensen, Jens Benn
    Skov, Torsten
    Mellemgaard, Anders
    APMIS, 2015, 123 (02) : 108 - 115
  • [6] Review of Plasma Exosomal DNA for Detecting EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
    Jahani, Mohammad Mehdi
    Mashayekhi, Parisa
    Omrani, Mir Davood
    Azimi Meibodi, Azita
    ADVANCED BIOMEDICAL RESEARCH, 2025, 14 (01):
  • [7] Beyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer
    Gkolfinopoulos, Stavros
    Mountzios, Giannis
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (08)
  • [8] EGFR mutations in non-small cell lung cancer - Clinical implications
    Charpidou, Andriani
    Blatza, Despoina
    Anagnostou, Elsa
    Syrigos, Konstantinos N.
    IN VIVO, 2008, 22 (04): : 529 - 536
  • [9] Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutations in Non-small Cell Lung Cancer (NSCLC): A Global Meta-analysis
    Melosky, B.
    Laack, E.
    Kambartel, K.
    Haentschel, M.
    Bennetts, M.
    Nickens, D.
    Brinkmann, J.
    Kayser, A.
    Moran, M.
    Cappuzzo, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S449 - S449
  • [10] KRAS Mutations as Prognostic and Predictive Markers in Non-Small Cell Lung Cancer
    Martin, Petra
    Leighl, Natasha B.
    Tsao, Ming-Sound
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (05) : 530 - 542
12345